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Abstract
Early detection and resection of adenomatous
polyps prevents their progression to colorectal
cancer (CRC), significantly improving patient
outcomes. Polyps are typically identified and
removed during white-light colonoscopy.
Unfortunately, the rate of interval cancers that
arise between CRC screening events remains
high, linked to poor visualization of polyps dur-
ing screening and incomplete polyp removal.
Here, we sought to evaluate the potential of a
hyperspectral endoscope (HySE) to enhance polyp discrimination for detection and
resection. We designed, built and tested a new compact HySE in a proof-of-concept
clinical study. We successfully collected spectra from three tissue types in seven
patients undergoing routine colonoscopy screening. The acquired spectral data from
normal tissue and polyps, both pre- and post- resection, were subjected to quantitative
analysis using spectral angle mapping and machine learning, which discriminated
the data by tissue type,meriting further investigation ofHySE as a clinical tool.
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1 | INTRODUCTION
Colorectal cancer (CRC) can develop from pre-cursor
lesions known as adenomatous polyps. Late stage CRC
has poor outcomes [1], but CRC can be prevented if ade-
nomatous polyps are detected and resected endoscopi-
cally before they progress [2]. Standard-of-care high-
definition white light colonoscopy is used for this
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purpose in a range of screening programmes, where
polyps are identified and removed via polypectomy dur-
ing the colonoscopy procedure. An interval cancer is
defined as CRC diagnosed after a colorectal screening
examination or test in which no cancer is detected, and
before the date of the next recommended exam [3]. The
rate of interval cancer has been found to be 1.1 to 2.7 per
1000 person-years of follow-up [4] and recent studies
have suggested that many interval cancers occur because
of missed lesions or incomplete removal of adenomatous
polyps at prior colonoscopy [4, 5]. At present, colonos-
copy provides only morphological colour images of the
colon, which presents challenges for identification of flat-
ter polyps or residual polyp tissue after resection, particu-
larly for larger polyps, as they are difficult to appreciate
relative to the background normal tissue.
To improve lesion visualization and prevent interval
cancers, many advanced colonoscopies have been intro-
duced [6], including: narrow-band imaging [7]; confocal
microendoscopy [8]; Raman spectroscopy [9]; and
hyperspectral endoscopy (HySE) [10, 11]. Narrow-band
imaging illuminates the tissue with a restricted wave-
length range of blue and green lights alternately, which
enhances the visibility of vascular and mucosal struc-
tures due to strong haemoglobin absorption at the selected
wavelengths. Nonetheless, detection of small or flat lesions
remains challenging and bleeding during resection can
obscure polyp margins. Confocal microendoscopy provides
morphological information at subcellular resolution, but
fluorescence labelling is needed and the field-of-view is very
small, meaning that identification of suspicious regions by
white-light colonoscopy is still needed prior to application.
Raman spectroscopy measures vibrational signatures from
the tissue with good discrimination between diseased and
healthy colonic tissue, however, it requires a very sensitive
optical setup and high-resolution spectrometer due to the
measurement of inelastic scattering light and similar to con-
focal microendoscopy is still dependent on white-light colo-
noscopy to guide placement of the Raman probe.
HySE relies on the optical absorption spectra of tis-
sue to discriminate disease based on changes in both
morphological and biochemical characteristics. These
spectral profiles could enable both detection and grad-
ing of disease in the gastrointestinal tract [11–13],
including for CRC diagnosis based on different spectral
profiles between normal mucosa and lesions [10,
14, 15]. By integrating line-scan hyperspectral imaging
with a standard white-light imaging approach, spectral
profiles can be obtained across a wide field-of-view dur-
ing endoscopy [13]. Here, we sought to evaluate the
potential of HySE as a visualization aid to enhance
polyp discrimination for detection and resection in a
proof-of-concept clinical study.
2 | METHODS
2.1 | Compact and mobile hyperspectral
endoscopy system
A HySE system reported previously [13] was optimized and
redesigned to make it more compact to increase mobility
for the clinical trial. The HySE system is designed and con-
structed using an accessory channel “babyscope”
(Polyscope, Polydiagnost, Germany) that can be introduced
through the accessory channel of a standard colonoscope.
The commercial CE-marked babyscope consists of a
10 000-fibrelet imaging bundle (PD-PS-0095, PolyDiagnost)
introduced into a disposable catheter (PD-PS-0144p,
PolyDiagnost) to relay diffusely reflected light from the
colon to custom external detection optics. The proximal end
of Polyscope was imaged and magnified by an infinity
corrected objective lens (40, NA 0.6, Nikon). To create a
more compact optical system compared to the previous
report, two tube lenses were replaced with a single tube lens
(f = 150 mm), which was put in front of non-polarizing
beam splitter cube (BS025, Thorlabs). Thus, wide-field and
spectral imaging shared the objective lens, tube lens, and
beam splitter, which minimised image distortions between
the wide-field colour (2D x,y) and spectral images (2D y,
wavelength λ) (Figure 1A). For hyperspectral imaging, a
spectrograph (IsoPlane 160, Princeton Instrument) with
grating (150 lines/mm) and electron-multiplied CCD cam-
era (ProEM 1024, Princeton Instrument) were used. The
spectral range of HySE was 400 to 800 nm with a spectral
resolution of ~2.5 nm. Lightfield v6.7 (Princeton Instru-
ments) was used to control the spectrograph and the
EMCCD camera. Labview 2017 (National Instruments) was
used for synchronized control of the wide-field camera,
spectrograph and EMCCD.
The HySE system was built on an aluminium bread-
board (600 mm  600 mm, Thorlabs) and enclosed by black
hardboards to protect sensitive image sensors from ambient
light in the theatre (Figure 1B,C). A self-centering mount
was used to make it easy to align and release the proximal
end of the fibre bundle from the optical imaging system
between patients. A supercontinuum light source (SuperK
Compact, NKT Photonics) was coupled to the illumination
fibre of the polyscope catheter for the fine alignment of the
hyperspectral endoscope and the guidance of endoscope
position during patient measurements. Hyperspectral data
capture was performed using the white light provided by the
standard-of-care colonoscope (Olympus CF-H290) as the
excitation source. The HySE system was subjected to careful
photothermal and photosafety evaluations (Figure 1D-F) to
ensure compliance with investigational device exemption
regulations. The methods used for photobiological safety
evaluation are detailed in the Supporting Information. The
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compact hyperspectral imaging system was placed on the
top of a trolley to allow the system to be moved to the the-
atre for patient measurements. In addition, the light source,
laptop, and optical components, including reference targets,
power meter, alignment tools, were mounted on the trolley,
making it convenient and simple to prepare the imaging sys-
tem ready for patient measurement within a limited time
frame.
2.2 | Patient recruitment and consent
We undertook a single-site proof-of-concept study
(ClinicalTrials.gov NCT04172493, first posted November
2019) at the Oregon Health and Sciences University
(OHSU), United States, to determine whether the use of
HySE can improve visualization of abnormal colonic tis-
sue. The HySE protocol is shown in Figure 1G. Eligible
participants were adults undergoing screening colonos-
copy that consented to the study. All 13 patients included
in the study were ASA:1 (American Society of Anesthesi-
ology score). The trial was reviewed by the OHSU Institu-
tional Review Board (IRB18947) following confirmation
by the FDA that HySE did not meet the definition of a
significant risk device under 21 CFR 812.3(m) of the
investigational device exemptions regulation and was
approved in June 2019. Participants underwent their
screening colonoscopy and polypectomy (as required)
according to the institutional standard-of-care. During
the procedure, HySE was used to image normal tissue,
FIGURE 1 Optical system and pilot clinical trial design. A, Schematics of the compact HySE (Left) and the method for capturing
hyperspectral images via a conventional colonoscope (Right). The HySE was assembled by exploiting a spectrograph, EMCCD camera,
CMOS colour camera, and minimum numbers of optical components. A sterilized endoscopic fibre with a disposable catheter was aligned
before a patient measurement. The endoscope was introduced through the accessory channel of the clinical colonoscope, and hyperspectral
imaging of patient colon was performed by sweeping the clinical colonoscope. B, C, Photos of the HySE system which was assembled on the
top of the trolley, carrying a light source, reference target, and calibration tools. D, E, Spectral irradiance and illumination angle of HySE
and the clinical colonoscope were compared to check photobiological safety of the proposed system. W.D.: working distance; D: diameter. F,
Surface temperature of the endoscope was assessed for 1 hour to test photothermal safety. G, Pilot trial design and experimental procedures
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colonic polyps prior to removal and residual tissue after
polyp removal (post-resection tissue). Successful acquisi-
tion of HySE data was possible in n = 7 patients. Initial
study recruitment was paused after n = 2 patients due to
institutional concerns with the sterility of the reusable
fibre bundle of the polyscope device. Subsequently, an
additional sterilisation procedure was introduced. A fur-
ther n = 11 patients were recruited, of which 8 underwent
the full trial protocol. In one patient measurement, it was
found that the accessory cap supporting the introduction
of surgical tools prevented HySE from reaching to the
distal end of the clinical colonoscope, and thus the acces-
sory cap was removed before introducing HySE in other
measurements. In 3 patients, their preparation was inad-
equate to continue with the study. Therefore, there were
useable data from seven patients in the second phase of
the trial, five of which had polyps (Table S1). Recruit-
ment was completed in January 2020. This was a non-
interventional study, so HySE was not used to inform on
any aspects of medical management. Acquired data were
analysed post-procedure in a video review with the
treating endoscopist.
2.3 | Hyperspectral endoscopy procedure
The hyperspectral endoscopy procedure is summarized in
a flow chart (Figure S3) and details of the procedure are
given below:
1. Optical fibre bundle was prepared for imaging
First, in order to avoid patient to patient cross-infec-
tion, the fibre bundle was sterilized according to the
manufacturer cleaning protocol before aligning with
the optical system. Briefly, the cleaning agents were
injected through the input channel of the fibre con-
tainer, and it was released at the output channel. After
washing the entire fibre with the same high-level dis-
infectants used for the sterile processing of the endo-
scopes the compressed air was injected through the
input channel of the fibre container to remove
the cleaning agents from the surface of the optics
fibre. The cleaning process was completed in the Ster-
ile Processing Department of OHSU within 40 to
60 minutes.
2. Informed consent was obtained to recruit a patient
Clinicians obtained an informed consent from an eli-
gible participant for the clinical study.
3. The sterile endoscope was aligned with the HySE system
Next, the trolley conveying the HySE system was
brought into the endoscopy suite and the polyscope
catheter and fibre bundle were aligned within
15 minutes, just before each patient measurement.
The illumination fibre coupled to the supercontinuum
light source was exploited for the fine adjustment of
the fibre bundle position to measure a perfect focused
image.
4. Colonoscopy and hyperspectral imaging was performed
The clinician first completed the screening colonoscopy
of the patients via the standard-of-care
colonoscopy, including white-light and narrow-band
imaging. After the examination, the operating clinician
decided on appropriate imaging regions for application
of HySE, including normal colonic mucosa and visually
detectable polyps. HySE was then introduced into the
accessory channel of the colonoscope. Light from
the supercontinuum source in the polyscope illumina-
tion fibre was used to aid in positioning the polyscope
at the distal end of the colonoscope. Once complete, the
supercontinuum source was turned off. The clinician
collected hyperspectral and wide-field colour images
simultaneously under white light illumination from the
colonoscope, acquiring 100 spectral and wide-field
images at each location while controlling the position-
ing of HySE with the colonoscope. Exposure times of
the spectral and wide-field imaging cameras were set at
57 and 35 ms, respectively. Polyp areas were examined
again after resection, with regions denoted as “post-
resection tissue.” The entire image acquisition process
was performed by the clinician.
5. The used optical fibre bundle was sent for cleaning.
After the patient measurement, HySE was removed
from the colonoscope. The disposable catheter was
removed and discarded. The fibre bundle was put in a
specialized carrier and sent to the sterilization team.
Two optical fibre bundles were used in the pilot study,
therefore, each fibre measured 6 and 4 patients,
respectively (Table S1).
6. Data analysis was performed after completion of the
procedure.
Data analysis methods are detailed in the Supporting
Information.
3 | RESULTS
3.1 | Wide-area hyperspectral image
reconstruction was successfully applied in
the colon
HySE operates on the basis of line-scan hyperspectral
imaging, which means that a 2D camera is included in
the spectrograph to record spectral profiles as a function
of position along one dimension. The second spatial
dimension is recorded by laterally scanning the endo-
scope across the colon lumen (Figure 2A,B). The full 3D
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data set, or hypercube, (spatial x, spatial y, wavelength λ)
is then stitched together using tracked spatial features in
the simultaneously recorded images from the colour cam-
era (Figure 2C). This feature tracking also compensates
for image distortions that arise due to patient motion. We
successfully stitched together panoramic images from the
colour camera (Figure 2D) and an associated panoramic
hyperspectral data cube (Figure 2E, Movies S2, S3) for
each acquisition. A synthetic RGB image composed from
the hyperspectral data cube as described previously
(Figure 2F) shows a clear lumen structure and obvious
vascular features and were used to extract tissue-specific
absorbance spectra (Figure 2G). These results confirm
that the HySE system and associated hyperspectral image
reconstruction method can successfully obtain hyper-
spectral data under clinical conditions despite the low
contrast images and distortions arising due to patient
motion.
3.2 | Coefficient of variation for
hyperspectral data was within 10%
In order to obtain tissue type-specific spectral profiles,
hyperspectral signals were investigated in areas clearly
identified by clinicians belonging to one of three groups:
normal colonic mucosa; polyp; or post-resection tissue,
present after polyp removal. In addition, hyperspectral
signals arising from specular reflections were also investi-
gated to ensure the accurate segmentation of spectral
data. The simultaneously recorded colour images were
used by the clinician to identify regions for quantitative
spectral analysis (Figures 3A and S2). The average spec-
tral profiles of each group clearly showed different shapes
with small SD.
In addition to the investigation of spectral profiles of
each group, intra- and inter-patient variations were also
assessed to check the quality of hyperspectral images. A
coefficient of variation (CV) was calculated as a function
of wavelength from spectra obtained in clearly identified
normal mucosa and polyps. Intra- and inter-patient varia-
tions show overall CVs were less than 10%, which is an
acceptable variability given the handheld nature of the
imaging device (Figure 3E,F).
3.3 | Absorbance spectra showed
promising differences between tissue types
As high-dimensional hyperspectral data would be challeng-
ing for an operating clinician to interpret in real-time, we
investigated the use of spectral angle mapping (SAM) to
provide a quantitative comparison between the spectra
recorded from different tissue types. SAM calculates the
angle between a target and a reference spectrum; the
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FIGURE 2 Reconstruction of a wide-area hyperspectral image exploiting machine vision methods. A, White-light colour images
captured with the colour camera, indicating the position of the spectrometer slit across the field of view. B, Raw spectral images captured by
the line-scanning spectrograph. C, Representative feature detection process from two sequential colour images. Matching features were
exploited to estimate geometric transformation matrices (GMs) used for stitching the panoramic images. D, Stitched panoramic colour image
obtained using estimated GMs. E, Representative slices of the stitched panoramic hyperspectral data cube at four different wavelengths. F, A
representative synthetic RGB image from the reconstructed hyperspectral data cube. G, Calculation of absorption data within the squares in
the synthetic RGB image
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FIGURE 3 Exemplar white-light images and spectral from normal mucosa and polyps. A-D, Representative wide-field images (top) of
normal mucosa, polyp, post-resection tissue, and specular reflection. Blue dashed line with grey shading indicates polyp annotated by a
clinician. Bottom graphs show the min-max normalized reflectance of normal, polyp, post-resection tissue, and specular reflection,
respectively. Black lines and grey areas indicate mean value and SD, respectively. E, F, Intra- and inter-patient coefficients of variation were
calculated to check the quality of hyperspectral images. Solid lines and grey areas indicate mean value and SD, respectively. Colours indicate
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FIGURE 4 Quantitative analysis of similarity of spectral signals of normal mucosa, polyp, post-resection tissue, and specular reflection
via spectral angle mapper (SAM). A, SAM was calculated based on average spectral signals of each tissue types as reference signals. Bar
graphs and vertical lines show mean value and SD, respectively. *** indicates P value <.001. Statistical analysis was performed using a one-
way analysis of variance (ANOVA) with post-hoc tests. B, A 3D plot of SAM values of normal mucosa, polyp, post-resection tissue, and
specular reflection calculated by three reference signals. C, Comparison between wide-field stitch images and synthetic RGB SAM images. A
synthetic RGB SAM images were created based on 1-SAM results obtained via three reference signals of normal mucosa (green), polyp
(blue), and post-resection tissue (red)
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reference signals are similar. SAM analysis conducted
using the average spectra from normal mucosa, polyp and
post-resection tissues shows statistically significant differ-
ences between tissue types (Figure 4A).
Visualizing these SAM scores in 3D clearly shows
4 clusters associated with the 3 tissue types and specular
reflection artefacts, indicating that SAM scores could
potentially be used for tissue identification and hence
image segmentation. We therefore developed a SAM-
based segmentation method that could be applied to the
real-time segmentation of line-scan hyperspectral data.
The line-areas corresponding to the spectrograph slit
position were extracted for sequential images from both
the colour camera (RGB) and spectral camera; these line-
areas were then placed adjacent to each other (Movie S3).
An associated SAM image was synthesized, by assigning
SAM scores for normal mucosa, polyps, and post-
resection tissue as green, blue, and red colours, respec-
tively (Figures 4C and S1). Encouragingly, the regions
identified by the SAM scores were consistent with the tis-
sue types annotated by the clinician.
3.4 | Machine learning enabled
classification of spectral images
We next tested a k-nearest neighbour (kNN) algorithm as
a classifier to predict the tissue type of newly observed
data. kNN does this by choosing the most frequent tissue
types of k-nearest neighbour data points in the feature
space (Figure 5A). Seventy percentage of the representa-
tive data displayed in Figure 4C were used for training
the kNN classifier, then the remaining 30% of data were
used as test dataset to validate the classifier via k-fold
cross-validation. The segmentation results based on the
established classifier were again consistent with the tis-
sue types confirmed by the clinician (Figure 5B, Movie
S3). It is worth noting that in the image representing
post-resection tissue only a small area of the wide-field
stitched image was occupied by that tissue type, but kNN
segmented result determined almost all of the tissue as
post-resection (Figures 5B and S2). These results indicate
that the kNN predicts areas of bleeding or blood-rich tis-
sue into the same tissue type and suggests a more com-
prehensive dataset is required for improved classification.
The kNN segmentation method was further applied to
other spectral imaging data in which the clinician found it
challenging to clearly identify polyps in our wide-field
images, either due to the small size of polyps or incomplete
scanning of the polyp during the HySE measurement. Spec-
tral data sets, containing 100 spectral images each, were
selected from 8 regions of normal mucosa and 5 regions
known to contain polyps that could not be spatially located
within our images. These data were used to determine
whether our segmentation showed any difference between
healthy and diseased colonic tissue based on a bulk classifi-
cation. For these data, we only had the knowledge of
whether the measured colon contained polyps or not, rather
than their specific location in our spatial data. We evaluated
the ratio of the overall area segmented as polyp compared to
normal in these data sets. The mean and SD of the polyp
ratio in normal mucosa and polyps were 3.17 ± 3.25 and
27.2 ± 13.9 respectively, indicating a statistically significant
increase (P value: .0169) in area classified as polyp in the
colons that contained polyps compared to the normal colon
(Figure 5C). These results suggest that a machine learning
based method could become a versatile tool for the segmen-
tation of hyperspectral data.
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FIGURE 5 Segmentation of raw spectral images based on a k-nearest neighbour (kNN) method. A, Schematic process of the
classification of spectral profiles based on kNN. B, Comparison between wide-field stitch images and classified results by kNN. C,
Classification ratio of polyps were quantified from hyperspectral images of patients with/without polyps. Bar graphs and vertical lines
indicate mean value and SD, respectively. Statistical analysis was performed using a Welch's t test
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4 | DISCUSSION
Early detection and resection of colonic polyps prevents
progression to CRC, yet interval cancers still arise
between screening visits, that can be in part attributed to
a combination of missed polyps and incomplete resec-
tions during standard colonoscopy. Using advanced opti-
cal imaging methods in colonoscopy has been proposed
to enhance polyp visualization and reduce the occurrence
of interval cancers. Here, we conducted a proof-of-
concept clinical study of one such technology, hyper-
spectral endoscopy.
A mobile HySE system was constructed and hyper-
spectral images of the colon of 10 patients, including spa-
tial and spectral information, were successfully
reconstructed by scanning HySE laterally across the
colon. Intrinsically co-registered wide-field colour images
were used to enable reconstruction of the full hyper-
spectral datacube. Having obtained the reconstructions,
clinician-annotated regions of normal mucosa, polyps
and post-resection tissue were subjected to quantitative
analyses. Firstly, SAM analysis with average reference
spectra obtained from the normal mucosa, polyps, and
post-resection tissue was exploited to convert the com-
plex spectral signals into three dimensional-data that
showed good discrimination between the tissue types and
also distinction from artefacts arising from specular
reflections. Secondly, a kNN algorithm was trained using
the SAM results together with the information about the
corresponding tissue types identified by the clinician.
The trained classifier was applied for the direct segmenta-
tion of the line-scan spectral images, which in future
could provide a route for online classification of polyps
within the line area of the hyperspectral system, without
the need for panoramic reconstruction.
While HySE has shown promise under clinical condi-
tions in the present study, this was a first experience of
applying the technology in patients and as such, two key
limitations emerged, which need to be resolved in future
studies. First, hyperspectral reconstruction was only
possible for colour images that showed clear structural
features of the colon. In order to acquire high-quality col-
our images, the position of HySE and the scanning proce-
dure were carefully controlled during data acquisition. If
HySE was placed too close to the tissue or the measured
colour image were blurred due to water flow or bleeding,
the computer vision algorithm used to compute the geo-
metric transformation matrices was unable to find signifi-
cant structural features, which compromised the
accuracy of wide-field image registration and subsequent
hyperspectral image reconstruction. This issue could be
overcome in future by exploiting advanced computa-
tional tools for image registration, such as deep
convolutional neural networks [16]. Even in conditions
where the wide-field registration failed, the wide-field
colour information was still helpful to compare the seg-
mentation results from spectral machine-learning with
conventional white-light colonoscopy methods.
A second limitation was the lack of gold standard his-
topathological annotation of the in vivo tissue types. The
operating clinicians in the study were established experts
in their field and annotated the tissue types using the
wide-field colour images provided by our HySE system.
These images are low-resolution compared to the images
obtained by conventional high definition white-light colo-
noscopy, making accurate annotation of the tissue type
challenging even for expert clinicians. The ground-truth
technique for the diagnosis of disease is histopathology,
but it would require additional biopsies to confirm the tis-
sue type for the normal mucosa and deeper resections to
take a biopsy sample following polyp resection. We were
therefore unable to include these steps in our pilot study,
but encouraged by our findings in this limited patient
cohort, a future clinical study could be designed to vali-
date our results and ensure histopathologic data of mea-
sured tissue could be obtained co-localised with spectral
data, which is expected to improve the accuracy of hyper-
spectral imaging based-disease diagnosis [17, 18].
In spite of these limitations, HySE has demonstrated
potential for clinical application. Given the promise in
the present pilot clinical study, the next steps are to
expand clinical trials of HySE to encompass other tissue
types (eg, sessile serrated polyps, flat polyp, and colorec-
tal cancer) and link the HySE data to the underlying his-
topathological diagnoses. Future trials will help us to test
whether HySE could accurately define normal and dis-
ease tissue in cases that are challenging with conven-
tional endoscopic methods, such as for flat polyps,
incomplete resections and also regular polyps arising in
patients with inflammatory bowel disease. If our prelimi-
nary results are validated in a larger patient cohort, HySE
could open up a new era for medical hyperspectral
imaging.
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